Pattern Bioscience
PrivateLast Round
Series D
Nov 18, 2025
Total Funding Raised
$131.85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pattern Bioscience is a biotechnology company that develops rapid, culture-free diagnostic technologies for identifying bacterial infections and determining antibiotic susceptibility.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pattern Bioscience Comparables
Compare Pattern Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SeLux Diagnostics | 86% | |
| Q-linea | 85% | |
| Resistell AG | 83% |
Pattern Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Nov 18, 2025 | ||||
| Grant | Nov 21, 2024 | ||||
| Series C | Apr 27, 2023 | ||||
| Series B Extension | Jul 14, 2020 | ||||
| Series B | Feb 4, 2020 | ||||
Grant | Feb 4, 2020 |
Key People
Founding team and executive leadership
Pattern Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AMR Action Fund | Series C, Series D |
| CARB-X | Grant |
| NIH RADx | Grant |
| Omnimed Capital | Series B Extension, Series C, Series D |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| National Institutes of Health (NIH) | Grant |
| Illumina Ventures | Series B Extension, Series C, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 306% MoM, reaching 15.1K.
- Mar 1, 2026
Implementing NetSuite for production and order-to-cash cycle.
Recent news
Latest coverage and updates
- is_developingOct 23, 2026
On Oct 23rd '26, Pattern Bioscience, Inc. is developing the urine ID/AST panel to identify the organism causing a urinary infection and its antimicrobial susceptibility directly from urine specimens, with same-day phenotypic AST.
Pattern Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pattern Bioscience's valuation, stock price, and market status.
Is Pattern Bioscience a public or private company?
Pattern Bioscience is a private company.
What is the current stock price of Pattern Bioscience?
Pattern Bioscience is a private company, so its shares have no public market price. Caplight tracks Pattern Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pattern Bioscience worth (valuation)?
Valuation information for Pattern Bioscience is not publicly available.
Can I buy Pattern Bioscience stock?
Pattern Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pattern Bioscience's last funding round?
Pattern Bioscience's most recent funding round was Series D on November 18, 2025.
Who are the main investors in Pattern Bioscience?
Key investors in Pattern Bioscience include AMR Action Fund, CARB-X, NIH RADx, Omnimed Capital, Public Health Emergency Medical Countermeasures Enterprise.
Will Pattern Bioscience IPO soon?
No public IPO plans have been announced for Pattern Bioscience.
How can I track Pattern Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Pattern Bioscience's shares on secondary markets.